Susama Chokesuwattanaskul

Susama Chokesuwattanaskul

Auto-generated profile, based on publicly available information

Susama Chokesuwattanaskul

Department of Ophthalmology, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Chulalongkorn University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2020 in Ophthalmic Epidemiology
Verified
Journal Article
Closed access
PSPongsant Supreeyathitikul
Pongsant Supreeyathitikul
SCSusama Chokesuwattanaskul
Susama Chokesuwattanaskul
JCJanejit Choovuthayakorn
Janejit Choovuthayakorn
DPDirek Patikulsila
Direk Patikulsila
NWNawat Watanachai
Nawat Watanachai
VCVoraporn Chaikitmongkol
Voraporn Chaikitmongkol
Purpose: To determine the characteristics and epidemiology of open globe injury (OGI) in a third referral centre over 11 years. Methods: The study was a retrospective observational study. The medical records of 978 OGI cases (a total of 998 eyes), admitted to Chiang Mai University Hospital, Thailand from January 2006 to December 2016, were reviewed. Results: The mean age (SD) of patients was 39.1 (17.5) years. Patients were predominantly male (867, 88.7%). The age with the highest incidence of injury ranged from 41 to 60 years, in both genders. Most injuries happened at the workplace (64.8%), with flying objects from electric grass trimmers (23.9%) being the major injury-related mechanism. Penetration injuries were found in 479 eyes (48.0%). In elderly group (aged >60 years), a higher proportion of a globe rupture injuries were observed (13.3%). In general, intraocular foreign body group presented with better initial visual acuity (VA) compared to other injury types (p< 0.001). In all types of injury, final VA was significantly improved after treatment. However, rupture and perforation globe injuries had significantly worse final VA outcomes, compared to penetration and intraocular foreign body injuries (p< 0.001). With multivariable regression analysis, poor initial VA (p< 0.001), type of injury (p= 0.028), positive relative afferent pupillary defect (RAPD) (p< 0.001), and endophthalmitis (p< 0.001) were associated with poor visual outcomes. Conclusions: Work-related eye injury is a major cause of OGI. Poor initial VA, endophthalmitis, presence of RAPD, and rupture were the predictors for poor final visual outcomes.

1 April 2021 in Rheumatology
Verified
Journal Article
Open access
PDF file
MAMichele Fresneda Alarcon
Michele Fresneda Alarcon
RGRudi Grosman
Rudi Grosman
SCSusama Chokesuwattanaskul
Susama Chokesuwattanaskul
MPMarie Phelan
Marie Phelan
HWHelen Wright
Helen Wright
Background/Aims Janus kinase inhibitors (JAKi) including baricitinib and tofacitinib target the JAK/STAT pathway and are clinically effective in treating rheumatoid arthritis (RA). Neutrophils play a key role in the pathophysiology of RA and their function is directly affected by these drugs as shown by clinical trials of JAKi which report increased infection rates and transient neutropenia during therapy. The aim of this work is to determine difference in the metabolome of neutrophils from healthy controls and patients with RA, and the effect of JAKi on the metabolome of healthy and RA neutrophils. Methods Neutrophils were isolated from healthy controls (HC) (n = 10) and patients with RA (n = 10 DMARD-naïve, n = 10 Biologics-naive) and pre-incubated with baricitinib, tofacitinib or a pan-JAK inhibitor (all 200ng/mL) for 2h before snap-freezing. Metabolites were extracted by 50:50 v/v AcN:H2O and analysed by 1H NMR spectroscopy using a 700 MHz Avance IIIHD Bruker NMR spectrometer equipped with a TCI cryoprobe. Chenomx, Bruker TopSpin and tameNMR software were used to identify metabolites and process spectra. Statistical analysis and machine learning models were implemented using R and the Mixomics package. Pathway analysis was carried out using Ingenuity (IPA). ROS production in response to 15 min fMLP stimulation was measured using DHR-123 and flow cytometry. Results At 0h, changes in levels of NADP+, NADPH and hypoxanthine in RA neutrophils indicated increased production of ROS via NADPH oxidase and xanthine oxidase compared to HC. Lower levels of glucose and increased levels of lactic acid also suggested increased glycolysis in RA neutrophils compared to HC. However after 2h incubation with JAKi, a difference in the response to these drugs was observed. 80 metabolites were higher in RA neutrophils compared to HC following 2h JAKi treatment. IPA analysis revealed the metabolites higher in RA neutrophils were involved in NAD biosynthesis, NAD phosphorylation/dephosphorylation, amino acid synthesis and transport, and carbohydrate metabolism. Changes in the levels of NADP+, NADPH and hypoxanthine in RA neutrophils indicate that JAKi inhibit ROS production. We therefore confirmed experimentally that JAKi inhibit ROS production in response to fMLP (p < 0.05). IPA also predicted altered neutrophil cell functions including cell death and cell-to-cell signalling. We previously showed that JAKi did not affect the constitutive rate of neutrophil apoptosis, however JAKi significantly inhibit the delay in apoptosis induced by GM-CSF (p < 0.05). No significant difference in the metabolome was observed when comparing tofacinib-treatment and baricitinib-treatment in either the HC or RA patient group. Conclusion The metabolome of RA and HC neutrophils is different at baseline. JAKi alter the levels of intracellular metabolites involved in neutrophil activation and ROS production in RA. This may explain, in part, the efficacy of JAKi in decreasing disease activity and joint damage in RA. Disclosure M. Fresneda Alarcon: None. R. Grosman: None. S. Chokesuwattanaskul: None. M. Phelan: None. H. Wright: None.

1 July 2024 in Biomedical Sciences and Clinical Medicine
Verified
Journal Article
Open access
PDF file
PAPongpawat Anujaree
Pongpawat Anujaree
JCJanejit Choovuthayakorn
Janejit Choovuthayakorn
SCSusama Chokesuwattanaskul
Susama Chokesuwattanaskul
CPChantawan Paspisanu
Chantawan Paspisanu
OBJECTIVE This study aimed to explore the epidemiological characteris-tics of primary and secondary diagnoses of eye injuries requiring hospitali-zation in a tertiary referral center. METHODS The medical records of 726 patients with diagnoses of eye injury who were admitted between January 2016 and December 2019 were reviewed. RESULTS Four hundred and thirty-six of the patients (60.1%) were hospitalized with a principal diagnosis related to eye injury, while 290 patients (39.9%) were admitted with secondary diagnoses. Over the four-year period of study, the proportion of admissions with a principal diagnosis stayed consistently in the range of 54.0% to 63.9%. Most of the patients in the principal diagnosis group were age between 41 and 60 years. Patients in the secondary diagnosis group, however, were mostly between the age of 21 and 40 years. The majority of patients in the principal diagnosis group (267 patients, 61.2%) had eye injuries which had occurred at work, whereas in the secondary diagnosis group most (230 patients, 79.3%) had eye injuries resulting from traffic accidents. CONCLUSIONS Work-related accidents and traffic accidents were the two main types of at-risk behaviors in both the primary and secondary diagnosis categories. Initiatives for public health education related to eye injuries should pay more special attention to these two primary causes of severe eye injuries. KEYWORDS principal diagnosis, secondary diagnosis, eye injury, hos- pitalization

31 August 2026 in Cornea
Verified
Journal Article
Closed access
LPLalida Pariyakanok
Lalida Pariyakanok
SCSusama Choksuwatnasakul
Susama Choksuwatnasakul
BABuravej Assavapongpaiboon
Buravej Assavapongpaiboon
CPChaturong Putaporntip
Chaturong Putaporntip
SJSomchai Jongwutiwes
Somchai Jongwutiwes
VSVannarut Satitpitakul
Vannarut Satitpitakul
Purpose: To report a rare case of refractory stromal keratitis caused by coinfection with Acanthamoeba and microsporidia in a systemically immunosuppressed patient. Methods: A 69-year-old woman with rheumatoid arthritis on systemic immunosuppressive therapy developed chronic keratitis after ocular trauma. Diagnosis was established through slit-lamp biomicroscopy, corneal scraping with modified trichrome and periodic acid–Schiff staining, culture on nonnutrient agar, polymerase chain reaction (PCR) with 18S rRNA gene sequencing, and in vivo confocal microscopy (IVCM). Treatment response and clinical outcomes were recorded. Results: Initial examination was consistent with microsporidial epithelial keratitis, which showed partial response to oral albendazole over 14 weeks. Progressive anterior-to-mid stromal infiltrates subsequently developed, refractory to antifungal therapy. Corneal scraping and IVCM demonstrated both microsporidial spores and Acanthamoeba cysts. Culture confirmed Acanthamoeba growth, and PCR with sequencing identified Acanthamoeba subgenotype T4B and Vittaforma corneae . Combination topical antimicrobial therapy led to ocular medicamentosa, and therapeutic penetrating keratoplasty was performed. Histopathology revealed residual microsporidial spores within keratocytes and degenerated Acanthamoeba cysts in the posterior stroma. At 3-month follow-up, the graft remained clear with no recurrence; best-corrected visual acuity was 20/125. Conclusions: Coinfection with Acanthamoeba and microsporidia should be considered in immunocompromised patients presenting with atypical, treatment-resistant keratitis. Prompt and parallel diagnostic evaluation—including corneal scraping, IVCM, culture, and PCR-based pathogen identification—is essential. When medical therapy fails, therapeutic keratoplasty may be required. Early comprehensive diagnosis may prevent disease progression and need for surgical intervention.

12 March 2026 in Ophthalmology Science
Verified
Journal Article
Open access
SCSusama Chokesuwattanaskul
Susama Chokesuwattanaskul
TSThanapong Somkijrungroj
Thanapong Somkijrungroj
FXFanxiu Xiong
Fanxiu Xiong
JGJohn A. Gonzales
John A. Gonzales
VSVannarut Satitpitakul
Vannarut Satitpitakul
To evaluate the comparative effectiveness of T-cell inhibitors versus antimetabolites on graft survival in high-risk penetrating keratoplasty (PKP), with a particular focus on cases of repeat grafting. Retrospective cohort study. All high-risk eyes undergoing optical PKP between 2015 and 2022 at King Chulalongkorn Memorial Hospital, Bangkok, Thailand. The medical records of 293 high-risk eyes undergoing optical PKP were reviewed. The use of any systemic steroid-sparing immunosuppressive (IS) agents was identified. In practice, all patients received either T-cell inhibitors or antimetabolites. Multivariable Cox proportional hazard models were applied to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) of the effect of systemic IS therapies on time to graft failure in high-risk PKP, adjusting for demographics, indications for PKP, and possible risk factors of graft failure. Time to graft failure in high-risk PKP. Among 281 high-risk eyes undergoing PKP, 217 received no IS medications, whereas 64 received IS medications (31 T-cell inhibitors, 49 antimetabolites). Notably, all eyes received topical corticosteroid immediately postoperation. In the multivariable Cox regression analysis adjusted for influential risk factors for graft failure, using any systemic IS was associated with a reduced risk of graft failure (HR: 0.71, 95% CI: 0.42–1.18), though not statistically significant. In subgroup analysis, T-cell inhibitors statistically significantly reduced the risk of graft failure (HR: 0.48, 95% CI: 0.24–0.95), whereas antimetabolites did not (HR: 0.97, 95% CI: 0.58–1.63). Among eyes with 2 or more previous grafts, IS use demonstrated a protective effect on graft failure (HR: 0.51, 95% CI: 0.28–0.94), but no benefit was observed for first-time grafts. Among IS medications for high-risk PKP, T-cell inhibitors, in addition to topical corticosteroid, significantly improved graft survival, whereas antimetabolites showed no benefit. The protective effect was most pronounced in repeat transplantation, suggesting T-cell inhibitors should be preferentially considered for eyes undergoing multiple grafts. The authors have no proprietary or commercial interest in any materials discussed in this article.

7 November 2026 in Eye
Verified
Journal Article
Closed access
PDF file
CKChatchada Kharuhayothin
Chatchada Kharuhayothin
SCSusama Chokesuwattanaskul
Susama Chokesuwattanaskul
BLBen LaHood
Ben LaHood
CTChulaluck Tangmonkongvorakul
Chulaluck Tangmonkongvorakul
NWNawat Watanachai
Nawat Watanachai